Related Experiment Video
Updated: Nov 23, 2025
05:36
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
716
Effects of Iron Chelation in Osteosarcoma
Maura Argenziano1, Alessandra Di Paola1, Chiara Tortora2
1Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Current Cancer Drug Targets
|December 31, 2020
Summary
Iron chelation with deferasirox and eltrombopag showed no direct impact on osteosarcoma cell progression. Further research into the tumor microenvironment is needed to explore potential therapeutic avenues for this aggressive bone cancer.
Area of Science:
- Oncology
- Biochemistry
- Pharmacology
Background:
- Osteosarcoma is an aggressive pediatric bone cancer with limited treatment options.
- Iron's role in cancer progression is increasingly recognized, leading to investigations into iron chelation therapy.
- Deferasirox and eltrombopag are iron chelators with demonstrated anticancer effects in other malignancies.
Purpose of the Study:
- To investigate the effects of deferasirox and eltrombopag on human osteosarcoma cells.
- To explore novel therapeutic strategies for osteosarcoma by targeting iron metabolism.
Main Methods:
- Human osteosarcoma cell lines (MG63 and 143B) were treated with deferasirox and eltrombopag, individually and in combination.
- Evaluated effects on cell viability, apoptosis, cell cycle, and reactive oxygen species (ROS) production using RTqPCR, Western Blotting, Iron Assay, and cytofluorimetric assays.
Main Results:
- Iron-chelating properties of deferasirox and eltrombopag were confirmed in osteosarcoma cells.
- No direct effect of these iron chelators on osteosarcoma cell progression, viability, apoptosis, cell cycle, or ROS production was observed.
Conclusions:
- Deferasirox and eltrombopag, despite their iron-chelating activity, do not directly influence the biochemical pathways critical for osteosarcoma progression and maintenance in vitro.
- Further research is warranted to explore potential indirect effects mediated by the tumor microenvironment.
